questionsmedicales.fr
Phénomènes psychologiques
Processus mentaux
Perception
Perception visuelle
Perception visuelle : Questions médicales fréquentes
Termes MeSH sélectionnés :
{
"@context": "https://schema.org",
"@graph": [
{
"@type": "MedicalWebPage",
"name": "Perception visuelle : Questions médicales les plus fréquentes",
"headline": "Perception visuelle : Comprendre les symptômes, diagnostics et traitements",
"description": "Guide complet et accessible sur les Perception visuelle : explications, diagnostics, traitements et prévention. Information médicale validée destinée aux patients.",
"datePublished": "2024-04-29",
"dateModified": "2025-04-24",
"inLanguage": "fr",
"medicalAudience": [
{
"@type": "MedicalAudience",
"name": "Grand public",
"audienceType": "Patient",
"healthCondition": {
"@type": "MedicalCondition",
"name": "Perception visuelle"
},
"suggestedMinAge": 18,
"suggestedGender": "unisex"
},
{
"@type": "MedicalAudience",
"name": "Médecins",
"audienceType": "Physician",
"geographicArea": {
"@type": "AdministrativeArea",
"name": "France"
}
},
{
"@type": "MedicalAudience",
"name": "Chercheurs",
"audienceType": "Researcher",
"geographicArea": {
"@type": "AdministrativeArea",
"name": "International"
}
}
],
"reviewedBy": {
"@type": "Person",
"name": "Dr Olivier Menir",
"jobTitle": "Expert en Médecine",
"description": "Expert en Médecine, Optimisation des Parcours de Soins et Révision Médicale",
"url": "/static/pages/docteur-olivier-menir.html",
"alumniOf": {
"@type": "EducationalOrganization",
"name": "Université Paris Descartes"
}
},
"isPartOf": {
"@type": "MedicalWebPage",
"name": "Perception",
"url": "https://questionsmedicales.fr/mesh/D010465",
"about": {
"@type": "MedicalCondition",
"name": "Perception",
"code": {
"@type": "MedicalCode",
"code": "D010465",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "F02.463.593"
}
}
},
"hasPart": [
{
"@type": "MedicalWebPage",
"name": "Clignement attentionnel",
"alternateName": "Attentional Blink",
"url": "https://questionsmedicales.fr/mesh/D054518",
"about": {
"@type": "MedicalCondition",
"name": "Clignement attentionnel",
"code": {
"@type": "MedicalCode",
"code": "D054518",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "F02.463.593.932.145"
}
}
},
{
"@type": "MedicalWebPage",
"name": "Perception des couleurs",
"alternateName": "Color Perception",
"url": "https://questionsmedicales.fr/mesh/D003118",
"about": {
"@type": "MedicalCondition",
"name": "Perception des couleurs",
"code": {
"@type": "MedicalCode",
"code": "D003118",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "F02.463.593.932.217"
}
}
},
{
"@type": "MedicalWebPage",
"name": "Perception du mouvement",
"alternateName": "Motion Perception",
"url": "https://questionsmedicales.fr/mesh/D009039",
"about": {
"@type": "MedicalCondition",
"name": "Perception du mouvement",
"code": {
"@type": "MedicalCode",
"code": "D009039",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "F02.463.593.932.567"
}
}
},
{
"@type": "MedicalWebPage",
"name": "Reconnaissance visuelle des formes",
"alternateName": "Pattern Recognition, Visual",
"url": "https://questionsmedicales.fr/mesh/D010364",
"about": {
"@type": "MedicalCondition",
"name": "Reconnaissance visuelle des formes",
"code": {
"@type": "MedicalCode",
"code": "D010364",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "F02.463.593.932.622"
}
},
"hasPart": [
{
"@type": "MedicalWebPage",
"name": "Reconnaissance faciale",
"alternateName": "Facial Recognition",
"url": "https://questionsmedicales.fr/mesh/D000066499",
"about": {
"@type": "MedicalCondition",
"name": "Reconnaissance faciale",
"code": {
"@type": "MedicalCode",
"code": "D000066499",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "F02.463.593.932.622.500"
}
}
}
]
},
{
"@type": "MedicalWebPage",
"name": "Clôture perceptive",
"alternateName": "Perceptual Closure",
"url": "https://questionsmedicales.fr/mesh/D010466",
"about": {
"@type": "MedicalCondition",
"name": "Clôture perceptive",
"code": {
"@type": "MedicalCode",
"code": "D010466",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "F02.463.593.932.677"
}
}
},
{
"@type": "MedicalWebPage",
"name": "Vision binoculaire",
"alternateName": "Vision, Binocular",
"url": "https://questionsmedicales.fr/mesh/D015348",
"about": {
"@type": "MedicalCondition",
"name": "Vision binoculaire",
"code": {
"@type": "MedicalCode",
"code": "D015348",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "F02.463.593.932.885"
}
}
},
{
"@type": "MedicalWebPage",
"name": "Vision monoculaire",
"alternateName": "Vision, Monocular",
"url": "https://questionsmedicales.fr/mesh/D015349",
"about": {
"@type": "MedicalCondition",
"name": "Vision monoculaire",
"code": {
"@type": "MedicalCode",
"code": "D015349",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "F02.463.593.932.893"
}
}
}
],
"about": {
"@type": "MedicalCondition",
"name": "Perception visuelle",
"alternateName": "Visual Perception",
"code": {
"@type": "MedicalCode",
"code": "D014796",
"codingSystem": "MeSH"
}
},
"author": [
{
"@type": "Person",
"name": "J Farley Norman",
"url": "https://questionsmedicales.fr/author/J%20Farley%20Norman",
"affiliation": {
"@type": "Organization",
"name": "Department of Psychological Sciences, Ogden College of Science and Engineering, Western Kentucky University, 1906 College Heights Blvd. #22030, Bowling Green, KY, 42101-2030, USA. farley.norman@wku.edu."
}
},
{
"@type": "Person",
"name": "Matan Mazor",
"url": "https://questionsmedicales.fr/author/Matan%20Mazor",
"affiliation": {
"@type": "Organization",
"name": "Institute of Neurology, Wellcome Centre for Human Neuroimaging, University College London, London, UK."
}
},
{
"@type": "Person",
"name": "Rani Moran",
"url": "https://questionsmedicales.fr/author/Rani%20Moran",
"affiliation": {
"@type": "Organization",
"name": "Institute of Neurology, Max Planck UCL Centre for Computational Psychiatry and Ageing Research, London, UK."
}
},
{
"@type": "Person",
"name": "Stephen M Fleming",
"url": "https://questionsmedicales.fr/author/Stephen%20M%20Fleming",
"affiliation": {
"@type": "Organization",
"name": "Institute of Neurology, Wellcome Centre for Human Neuroimaging, University College London, London, UK."
}
},
{
"@type": "Person",
"name": "Johan Wagemans",
"url": "https://questionsmedicales.fr/author/Johan%20Wagemans",
"affiliation": {
"@type": "Organization",
"name": "Laboratory of Experimental Psychology, Department of Brain and Cognition, Faculty of Psychology and Educational Sciences, KU Leuven, Tiensestraat 102 - box 3711, 3000, Leuven, Belgium."
}
}
],
"citation": [
{
"@type": "ScholarlyArticle",
"name": "BMP-2 and IL-1β as Markers of Nasal Mucosa Inflammation in Rhinosinusitis with Nasal Polyps.",
"datePublished": "2023-03-13",
"url": "https://questionsmedicales.fr/article/36913089",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1007/s10517-023-05728-y"
}
},
{
"@type": "ScholarlyArticle",
"name": "Distinct subsets of innate lymphoid cells in nasal polyp.",
"datePublished": "2022-07-20",
"url": "https://questionsmedicales.fr/article/35868977",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1016/j.alit.2022.06.007"
}
},
{
"@type": "ScholarlyArticle",
"name": "Outcomes of biological therapy in patients with severe asthma with chronic rhinosinusitis in Saudi Arabia: patients with nasal polyps versus those without nasal polyps.",
"datePublished": "2024-07-08",
"url": "https://questionsmedicales.fr/article/38978039",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1186/s12890-024-03139-x"
}
},
{
"@type": "ScholarlyArticle",
"name": "Identification of Inflammatory Endotypes by Clinical Characteristics and Nasal Secretion Biomarkers in Chronic Rhinosinusitis with Nasal Polyps.",
"datePublished": "2023-05-30",
"url": "https://questionsmedicales.fr/article/37253337",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1159/000530193"
}
},
{
"@type": "ScholarlyArticle",
"name": "Diagnostic value and underlying mechanism of nasal nitric oxide in eosinophilic chronic rhinosinusitis with nasal polyps.",
"datePublished": "2023-05-22",
"url": "https://questionsmedicales.fr/article/37224640",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1016/j.molimm.2023.05.004"
}
}
],
"breadcrumb": {
"@type": "BreadcrumbList",
"itemListElement": [
{
"@type": "ListItem",
"position": 1,
"name": "questionsmedicales.fr",
"item": "https://questionsmedicales.fr"
},
{
"@type": "ListItem",
"position": 2,
"name": "Phénomènes psychologiques",
"item": "https://questionsmedicales.fr/mesh/D011579"
},
{
"@type": "ListItem",
"position": 3,
"name": "Processus mentaux",
"item": "https://questionsmedicales.fr/mesh/D008606"
},
{
"@type": "ListItem",
"position": 4,
"name": "Perception",
"item": "https://questionsmedicales.fr/mesh/D010465"
},
{
"@type": "ListItem",
"position": 5,
"name": "Perception visuelle",
"item": "https://questionsmedicales.fr/mesh/D014796"
}
]
}
},
{
"@type": "MedicalWebPage",
"name": "Article complet : Perception visuelle - Questions et réponses",
"headline": "Questions et réponses médicales fréquentes sur Perception visuelle",
"description": "Une compilation de questions et réponses structurées, validées par des experts médicaux.",
"datePublished": "2025-05-17",
"inLanguage": "fr",
"hasPart": [
{
"@type": "MedicalWebPage",
"name": "Diagnostic",
"headline": "Diagnostic sur Perception visuelle",
"description": "Comment évaluer la perception visuelle ?\nQuels examens pour troubles de la perception ?\nQuels signes indiquent un problème visuel ?\nQuand consulter un spécialiste de la vue ?\nQuelles sont les causes de troubles visuels ?",
"url": "https://questionsmedicales.fr/mesh/D014796?mesh_terms=Nasal+Polyps&page=2#section-diagnostic"
},
{
"@type": "MedicalWebPage",
"name": "Symptômes",
"headline": "Symptômes sur Perception visuelle",
"description": "Quels symptômes de troubles de la perception ?\nComment reconnaître une illusion visuelle ?\nQu'est-ce que l'agnosie visuelle ?\nQuels signes d'une fatigue visuelle ?\nComment se manifeste la synesthésie visuelle ?",
"url": "https://questionsmedicales.fr/mesh/D014796?mesh_terms=Nasal+Polyps&page=2#section-symptômes"
},
{
"@type": "MedicalWebPage",
"name": "Prévention",
"headline": "Prévention sur Perception visuelle",
"description": "Comment prévenir les troubles de la perception ?\nQuel rôle joue l'alimentation sur la vision ?\nComment réduire la fatigue visuelle ?\nPourquoi éviter le tabac pour la vision ?\nL'exercice physique aide-t-il la vision ?",
"url": "https://questionsmedicales.fr/mesh/D014796?mesh_terms=Nasal+Polyps&page=2#section-prévention"
},
{
"@type": "MedicalWebPage",
"name": "Traitements",
"headline": "Traitements sur Perception visuelle",
"description": "Quels traitements pour troubles de la perception ?\nComment la thérapie visuelle aide-t-elle ?\nLes lunettes corrigent-elles la perception ?\nQuand envisager une chirurgie oculaire ?\nQuels médicaments pour troubles visuels ?",
"url": "https://questionsmedicales.fr/mesh/D014796?mesh_terms=Nasal+Polyps&page=2#section-traitements"
},
{
"@type": "MedicalWebPage",
"name": "Complications",
"headline": "Complications sur Perception visuelle",
"description": "Quelles complications des troubles visuels ?\nComment les troubles visuels affectent-ils la vie quotidienne ?\nQuels risques de dépression avec troubles visuels ?\nLes troubles de la perception peuvent-ils s'aggraver ?\nQuelles sont les conséquences d'une agnosie visuelle ?",
"url": "https://questionsmedicales.fr/mesh/D014796?mesh_terms=Nasal+Polyps&page=2#section-complications"
},
{
"@type": "MedicalWebPage",
"name": "Facteurs de risque",
"headline": "Facteurs de risque sur Perception visuelle",
"description": "Quels facteurs de risque pour troubles visuels ?\nLe diabète augmente-t-il les risques visuels ?\nComment l'hypertension affecte-t-elle la vision ?\nLe stress influence-t-il la perception visuelle ?\nLes antécédents de traumatismes oculaires sont-ils un risque ?",
"url": "https://questionsmedicales.fr/mesh/D014796?mesh_terms=Nasal+Polyps&page=2#section-facteurs de risque"
}
]
},
{
"@type": "FAQPage",
"mainEntity": [
{
"@type": "Question",
"name": "Comment évaluer la perception visuelle ?",
"position": 1,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des tests de vision, comme l'optométrie, évaluent la perception visuelle."
}
},
{
"@type": "Question",
"name": "Quels examens pour troubles de la perception ?",
"position": 2,
"acceptedAnswer": {
"@type": "Answer",
"text": "L'IRM et l'électrorétinogramme aident à diagnostiquer les troubles de la perception."
}
},
{
"@type": "Question",
"name": "Quels signes indiquent un problème visuel ?",
"position": 3,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des difficultés à voir, des illusions ou des distorsions visuelles peuvent indiquer un problème."
}
},
{
"@type": "Question",
"name": "Quand consulter un spécialiste de la vue ?",
"position": 4,
"acceptedAnswer": {
"@type": "Answer",
"text": "Consultez un ophtalmologiste si vous ressentez des changements soudains de vision."
}
},
{
"@type": "Question",
"name": "Quelles sont les causes de troubles visuels ?",
"position": 5,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les causes incluent les maladies oculaires, les traumatismes et les troubles neurologiques."
}
},
{
"@type": "Question",
"name": "Quels symptômes de troubles de la perception ?",
"position": 6,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les symptômes incluent la vision floue, les halos, et les difficultés de profondeur."
}
},
{
"@type": "Question",
"name": "Comment reconnaître une illusion visuelle ?",
"position": 7,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les illusions visuelles se manifestent par des perceptions erronées d'objets ou de couleurs."
}
},
{
"@type": "Question",
"name": "Qu'est-ce que l'agnosie visuelle ?",
"position": 8,
"acceptedAnswer": {
"@type": "Answer",
"text": "L'agnosie visuelle est l'incapacité de reconnaître des objets malgré une vision intacte."
}
},
{
"@type": "Question",
"name": "Quels signes d'une fatigue visuelle ?",
"position": 9,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les signes incluent des maux de tête, des yeux secs et une vision floue après un usage prolongé."
}
},
{
"@type": "Question",
"name": "Comment se manifeste la synesthésie visuelle ?",
"position": 10,
"acceptedAnswer": {
"@type": "Answer",
"text": "La synesthésie visuelle se manifeste par des associations involontaires entre couleurs et sons."
}
},
{
"@type": "Question",
"name": "Comment prévenir les troubles de la perception ?",
"position": 11,
"acceptedAnswer": {
"@type": "Answer",
"text": "Protégez vos yeux avec des lunettes de soleil et faites des examens réguliers."
}
},
{
"@type": "Question",
"name": "Quel rôle joue l'alimentation sur la vision ?",
"position": 12,
"acceptedAnswer": {
"@type": "Answer",
"text": "Une alimentation riche en vitamines A, C et E peut aider à maintenir une bonne vision."
}
},
{
"@type": "Question",
"name": "Comment réduire la fatigue visuelle ?",
"position": 13,
"acceptedAnswer": {
"@type": "Answer",
"text": "Faites des pauses régulières lors de l'utilisation d'écrans pour réduire la fatigue visuelle."
}
},
{
"@type": "Question",
"name": "Pourquoi éviter le tabac pour la vision ?",
"position": 14,
"acceptedAnswer": {
"@type": "Answer",
"text": "Le tabac augmente le risque de maladies oculaires comme la dégénérescence maculaire."
}
},
{
"@type": "Question",
"name": "L'exercice physique aide-t-il la vision ?",
"position": 15,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, l'exercice régulier améliore la circulation sanguine, bénéfique pour la santé oculaire."
}
},
{
"@type": "Question",
"name": "Quels traitements pour troubles de la perception ?",
"position": 16,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les traitements incluent la thérapie visuelle, les lunettes et parfois la chirurgie."
}
},
{
"@type": "Question",
"name": "Comment la thérapie visuelle aide-t-elle ?",
"position": 17,
"acceptedAnswer": {
"@type": "Answer",
"text": "La thérapie visuelle améliore la coordination œil-main et la perception visuelle."
}
},
{
"@type": "Question",
"name": "Les lunettes corrigent-elles la perception ?",
"position": 18,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, les lunettes corrigent les erreurs de réfraction et améliorent la perception visuelle."
}
},
{
"@type": "Question",
"name": "Quand envisager une chirurgie oculaire ?",
"position": 19,
"acceptedAnswer": {
"@type": "Answer",
"text": "La chirurgie est envisagée pour des problèmes structurels comme la cataracte ou le glaucome."
}
},
{
"@type": "Question",
"name": "Quels médicaments pour troubles visuels ?",
"position": 20,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des médicaments peuvent traiter des conditions comme le glaucome ou les infections oculaires."
}
},
{
"@type": "Question",
"name": "Quelles complications des troubles visuels ?",
"position": 21,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les complications incluent la perte de vision, l'isolement social et des troubles émotionnels."
}
},
{
"@type": "Question",
"name": "Comment les troubles visuels affectent-ils la vie quotidienne ?",
"position": 22,
"acceptedAnswer": {
"@type": "Answer",
"text": "Ils peuvent limiter les activités quotidiennes, affecter le travail et la mobilité."
}
},
{
"@type": "Question",
"name": "Quels risques de dépression avec troubles visuels ?",
"position": 23,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les troubles visuels augmentent le risque de dépression en raison de l'isolement social."
}
},
{
"@type": "Question",
"name": "Les troubles de la perception peuvent-ils s'aggraver ?",
"position": 24,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, sans traitement, certains troubles de la perception peuvent s'aggraver avec le temps."
}
},
{
"@type": "Question",
"name": "Quelles sont les conséquences d'une agnosie visuelle ?",
"position": 25,
"acceptedAnswer": {
"@type": "Answer",
"text": "L'agnosie visuelle peut entraîner des difficultés dans la reconnaissance d'objets et des interactions sociales."
}
},
{
"@type": "Question",
"name": "Quels facteurs de risque pour troubles visuels ?",
"position": 26,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les facteurs incluent l'âge, les antécédents familiaux et les maladies chroniques."
}
},
{
"@type": "Question",
"name": "Le diabète augmente-t-il les risques visuels ?",
"position": 27,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, le diabète peut causer des complications oculaires comme la rétinopathie diabétique."
}
},
{
"@type": "Question",
"name": "Comment l'hypertension affecte-t-elle la vision ?",
"position": 28,
"acceptedAnswer": {
"@type": "Answer",
"text": "L'hypertension peut endommager les vaisseaux sanguins de l'œil, entraînant des troubles visuels."
}
},
{
"@type": "Question",
"name": "Le stress influence-t-il la perception visuelle ?",
"position": 29,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, le stress peut affecter la concentration et la clarté de la perception visuelle."
}
},
{
"@type": "Question",
"name": "Les antécédents de traumatismes oculaires sont-ils un risque ?",
"position": 30,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, les traumatismes oculaires augmentent le risque de troubles de la perception visuelle."
}
}
]
}
]
}
Rhinosinusitis with nasal polyps is characterized by chronic inflammation and hyperplasia of the nasal mucosa. The key mechanism for polyp formation is the expression of molecules that regulate prolif...
Group 2 innate lymphoid cells (ILC2s) contribute to the pathogenesis of eosinophilic chronic rhinosinusitis with nasal polyps (CRSwNPs). However, the role of other subsets of ILCs and the differentiat...
ILC subsets and ILCPs were evaluated by flow cytometry in fresh sinonasal mucosa from patients with CRSwNPs and control subjects. Subsets were compared based on clinical variables and immunological fe...
The frequency of ILC1s and IFN-γ-producing ILC1s increased in non-eosinophilic NPs, whereas that of ILC2s and IL-5-producing ILC2s increased in eosinophilic NPs, particularly in patients with comorbid...
ILC1s and ILC2s may be associated with neutrophilic and eosinophilic inflammation in CRSwNPs, respectively. In addition, ILCPs located in the sinus mucosa could differentiate into IFN-γ- or IL-5-produ...
This study's purposes were to evaluate the impact of biological therapies on outcomes in patients with severe asthma (SA) and chronic rhinosinusitis (CRS) and to compare these effects among those with...
From March to September 2022, a retrospective observational cohort study was undertaken at the severe asthma clinics of the Armed Forces Hospital-Southern Region (AFHSR) and King Khalid University Hos...
Fifty subjects were enrolled, with a mean age of 46.56. There were 27 (54%) females and 23(46%) males. Significant improvements in clinical parameters (frequency of asthma exacerbations and hospitaliz...
Patients with CRS experienced significant improvements in clinical, FEV1, and laboratory outcomes after dupilumab therapy. However, these improvements were not maintained when comparing CRSwNP with CR...
The emergency of biologics and surgical techniques targeting the specific inflammatory endotype in chronic rhinosinusitis with nasal polyps (CRSwNP) asks for efficient identification of patients with ...
Six mediators in sinonasal tissue and 36 mediators in nasal secretion samples were detected by the Bio-Plex suspension array system. Mucosal IFN-γ and IL-17A levels were used to define the T1 and T3 e...
Among mucosal IL-4, IL-5, IL-13, and IgE, IL-13 was the best one to coincide with the expression of other T2 biomarkers. A combination of atopy, facial pain symptom score, ethmoid/maxillary computed t...
IL-13 is a primary anchor for the T2 endotype in CRSwNP. Clinical characteristics and nasal secretion biomarkers are helpful for identifying the T2 and T3 endotype of CRSwNP....
Nitric oxide (NO) is an important messenger molecule widely present in the human body. However, the role of nasal NO (nNO) in eosinophilic chronic rhinosinusitis with nasal polyps (Eos CRSwNP) remain ...
The medical records of 84 non-Eos CRSwNP patients, 55 Eos CRSwNP patients, and 37 control subjects were retrospectively reviewed. The diagnostic value of nNO for Eos CRSwNP was assessed. The expressio...
The nNO levels of the CRSwNP group were significantly lower than those of the control group. Compared with the non-Eos CRSwNP group, the Eos CRSwNP group showed higher nNO level. The combination of nN...
nNO may have a high diagnostic value in Eos CRSwNP, and Akt/eNOS pathway may promote the generation of NO to protect TJs. NO may have a potentially important role in the diagnosis and treatment of Eos...
Transglutaminase (TGM) isoform catalyze the cross-linking reaction of identical or different substrate proteins. Eosinophil has been recognized in chronic rhinosinusitis with nasal polyps (CRSwNP) for...
Chronic rhinosinusitis with nasal polyps (CRSwNP) is associated with inflammation and tissue remodeling including myofibroblasts differentiation and extracellular matrix (ECM) deposition mediated by T...
Chronic rhinosinusitis (CRS) is an inflammatory disease affecting more than 10% of the global adult population. It is classified into Th1, Th2, and Th17 endotypes and eosinophilic and non-eosinophilic...
To elucidate the role of eosinophils in inducing fibrin deposition in CRS nasal polyp tissues and explore potential regulatory mechanisms....
We analyzed the expression of genes related to the serpin family and fibrinolytic system using Gene Expression Omnibus and Next-generation sequencing data. Differentially expression genes (DEGs) analy...
Nasal polyp tissues showed upregulated PAI-1, u-PA, and u-PAR expression and downregulated t-PA expression. Fibrinolytic system-related genes positively correlated with Th2 cytokines, except for t-PA....
CHI3L1 contributes to fibrin deposition by impairing the fibrinolytic system during nasal polyp formation. The regulation of CHI3L1 expression may inhibit fibrin deposition and edema in ECRS, presenti...
A clear understanding of the pathophysiology of chronic rhinosinusitis with nasal polyps (CRSwNP) and its close association with other airway pathologies, especially asthma, helps to comprehend the co...
This expert review is the synthesis of a working group on the current state of the art of the evaluation and management of CRSwNP. A thorough analysis of the literature has been conducted for the late...
The roles of optimal medical treatment and indications for surgery are becoming clearer, but much research is still needed regarding the extent and radicality when surgery is indicated. The main objec...
To examine whether and how interleukin (IL)-1α is involved in chronic rhinosinusitis with nasal polyps (CRSwNP)....
Nasal polyp (NP) and control tissues were collected from CRSwNP patients and control subjects. The expression of IL-1α and other proinflammatory cytokines (IL-1β, IL-8 and IL-13, etc.), as well as neu...
The mRNA and protein levels of IL-1α were significantly higher in NP tissues compared to that in control tissues. IL-1α in polyp tissues was mainly located in epithelial cells and neutrophils. Polyps ...
These findings provided the evidence that IL-1α were significantly increased in NP tissues, which may contribute to tissue neutrophilia in CRSwNP patients in China....